Long-term survival in individuals with metastatic, relapsed, or repeated Ewing sarcoma

Long-term survival in individuals with metastatic, relapsed, or repeated Ewing sarcoma and rhabdomyosarcoma is normally dismal. regressions pursuing short-term treatment, in comparison to typical irinotecan. Gene appearance evaluation performed on xenograft tumors treated with either irinotecan or STA-8666 demonstrated that STA-8666 affected appearance of DNA harm and fix genes even more robustly than irinotecan. These… Continue reading Long-term survival in individuals with metastatic, relapsed, or repeated Ewing sarcoma